CellaVision AB (publ) (LON:0MR5)
178.20
-2.90 (-1.60%)
At close: Oct 17, 2025
CellaVision AB Revenue
CellaVision AB had revenue of 191.33 million SEK in the quarter ending June 30, 2025, with 1.88% growth. This brings the company's revenue in the last twelve months to 751.47 million, up 3.45% year-over-year. In the year 2024, CellaVision AB had annual revenue of 723.22 million with 6.78% growth.
Revenue (ttm)
751.47M SEK
Revenue Growth
+3.45%
P/S Ratio
5.98
Revenue / Employee
3.43M SEK
Employees
219
Market Cap
345.16M GBP
Revenue Chart
* This company reports financials in SEK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 723.22M | 45.93M | 6.78% |
Dec 31, 2023 | 677.29M | 37.95M | 5.94% |
Dec 31, 2022 | 639.34M | 73.79M | 13.05% |
Dec 31, 2021 | 565.55M | 94.11M | 19.96% |
Dec 31, 2020 | 471.44M | 9.67M | 2.09% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Shell | 198.54B |
BP p.l.c. | 134.89B |
Unilever | 51.24B |
AstraZeneca | 41.24B |
HSBC Holdings | 41.03B |
Rio Tinto Group | 39.22B |
GSK plc | 31.63B |
BAE Systems | 27.41B |